Result preview: What to expect from F&P Healthcare
F&P Healthcare is expected to report a sharp fall in annual net profit on Wednesday.
AdvertisementAdvertise with NZME.
Latest fromFisher and Paykel Healthcare
Market close: Investors offload Ryman, F&P Healthcare shares
The New Zealand sharemarket opened the week with more than a 1 per cent fall.
F&P Healthcare share price drops after revenue guidance
The previous year's revenue came to $1.97b.
Deloitte Top 200 Award finalists named
The best of business in New Zealand set to be honoured in the annual Top 200 awards.
F&P Healthcare H1 profit down 2%, beats market expectations
Fisher & Paykel Healthcare has released its first half result.
Preview: What to expect from F&P Healthcare's first-half result
Market's attention will be on what lies ahead as more countries come to grips with Covid.
F&P Healthcare's revenue edged back from Covid highs
F&P Healthcare's turnover edged lower in the first four months of its financial year.
Strong start to annual results fails to lift NZ sharemarket
For the second day running, the New Zealand sharemarket was driven down by F&P Healthcare.
Brokers' Picks: The best and worst performing shares at mid-year point
Mid-year results in the Herald Brokers Picks game don't all reflect the NZX-50 returns.
F&P Healthcare's shares plunge after record $524m profit
The respiratory products maker recorded a record profit of more than $500m.
Opinion: The exposures facing healthcare sector growth
F&P Healthcare and Ryman have been standouts among Australasian healthcare companies.
Epsom double killings: The family at the centre of a tragedy
Loving family photo shared online weeks before killings.
NZ imports fell sharply in 2020 - Stats NZ
NZ's imports plummeted in 2020 while exports remained strong, Stats NZ says.
Pandemic profits: F&P Healthcare shares climb on profit upgrade
New Zealand's largest listed company upgrades full-year profit again.
Brokers' Picks: The hot stocks to watch in 2021
Brokers select their top five companies for 2021 in our annual stock picking game.
Deloitte Top 200: Company of the year overcomes adversity of 2020
Fisher & Paykel Healthcare reaps rewards.
Analysts ponder F&P Healthcare in a post-Covid world
F&P Healthcare's first-half profit leapt by 86 per cent, driven by Covid-19 demand.
Liam Dann: Despite vaccine news, war is far from over
Vaccine is no silver bullet but at least brings the horizons of this crisis into focus.
Market close: NZ shares end firmer, while FPH and a2 Milk ease
Trade thinned out before the long Labour Day weekend.
F&P Healthcare's huge earnings upgrade - is there more to come?
Could F&P Healthcare's earnings upgrade be too conservative?
F&P Healthcare stock rallies sharply on earnings update
F&P Healthcare said Covid-19 demand would drive earnings sharply higher in 2021.
NZ corporate earnings are in a state of flux
The re-emergency of Covid-19 has cast more doubt on NZ corporate earnings.
Sharemarket drops sharply on fresh Covid cases, Auckland lockdown
Kiwi dollar steady but shares take a hit.
Oliver Mander: Robust returns for F&P Healthcare shareholders
Innovative company has looked after the health of its customers -- and its investors.
Fisher & Paykel Healthcare on hiring spree
F&P Healthcare has hired some 600 additional direct manufacturing staff locally.
F&P Healthcare delivers another record profit, but is it sustainable?
F&P Healthcare has delivered another record profit, but is its growth sustainable?
F&P Healthcare shares spike after profit hits record
The company's net profit is tipped to grow even more next year.
Airfreight exports of NZ respiratory products boomed in March - AIA
Airfreighted exports of respiratory products shot higher in March, AIA says.
Continuous Disclosure: Why investors are lining up for NZ recapitalisation plans
Plus, is Sky City next in line to raise capital?
Continuous Disclosure: Sharemarket's biggest company keeps going up
Plus, Heartland shareholders still waiting for clarity.
F&P Healthcare shares rally sharply after earnings upgrade
F&P Healthcare's respiratory products are used in treating patients with coronavirus.
F&P Healthcare shares spike after earnings upgrade
Firm expects full year operating revenue to be $1.17b for net profit of about $245m-$255m.